Atherosclerotic Carotid Artery Occlusion

Area of Science:

• Neurology
• Vascular Surgery
• Cardiology

Background:

• Atherosclerotic carotid artery occlusion (ACAO) is a significant cause of acute ischemic stroke.
• Effective management strategies are crucial for improving patient outcomes and preventing recurrent events.

Purpose of the Study:

• To outline evidence-based recommendations for the acute management of stroke due to ACAO.
• To provide guidance on secondary prevention strategies for patients with ACAO.
• To evaluate the efficacy of surgical and endovascular interventions for ACAO.

Main Methods:

• Review of current clinical guidelines and evidence for stroke management.
• Analysis of treatment outcomes for intravenous thrombolysis, antiplatelet therapy, anticoagulation, and surgical interventions.
• Assessment of data regarding lifestyle modifications and risk factor intervention.

Main Results:

• Intravenous tissue plasminogen activator is recommended for eligible acute stroke patients with ACAO.
• Aspirin is indicated for patients with ACAO not eligible for thrombolysis; heparin is not recommended.
• Medical therapy, including lifestyle changes and aspirin, is the primary prevention strategy; bypass surgery offers no general benefit.

Conclusions:

• Optimal management of acute stroke due to ACAO involves timely thrombolysis or aspirin therapy.
• Long-term stroke prevention focuses on medical management and risk factor control.
• Surgical and endovascular interventions are generally not indicated for ACAO, except in specific clinical trial settings.